Send feedback

PAH p.Phe55fs

c.165del · rs199475566 · VCV611

Pathogenic Expert panel
Classification
Pathogenic
ClinVar
Review
Expert panel ★★★☆
ClinVar · 14 submitters
Consequence
frameshift
predicted LoF
gnomAD v4.1
Rare
very rare (popmax 0.00239%, nfe)
Conditions
1
phenylketonuria

ClinGen expert panel — Phenylketonuria VCEP

Pathogenic for phenylketonuria. Applied ACMG criteria (verbatim):

PM2 PVS1 PP4

Curation rationale (ClinGen, verbatim)

The c.165delT (p.F55Lfs*6) is a frameshift variant in exon 2 of 13 in PAH, predicted to undergo nonsense mediated decay with the truncated region critical to protein function. It has been reported in compound heterozygote state in multiple patients with PKU (BH4 deficiency not excluded) (PMID: 1682235 & 23500595). The variants in trans include: R408W, and R261Q, both confirmed pathogenic.This variant has an extremely low allele frequency in the Genome Aggregation database (3/251384) (PM2). In summary, this variant meets criteria to be classified as pathogenic for PAH. PAH-specific ACMG/AMP criteria: PM2, PP4, PVS1.

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Consequenceframeshiftpredicted loss-of-function
NMDpredictedpremature termination codon in exon 2 of 13
Splicing
SpliceAI—not assessed · substitutions only
Constraint at this position
ConservationphyloP 7.7GERP 2, phastCons 1
Overall
CADD26.1PHRED · no single calibrated threshold — expert panels disagree

Predicted loss-of-function is descriptive, not an applied PVS1 code.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00239% European (non-Finnish) · 28/1,170,792 alleles
Filtering AF 0.00166% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00143%
Overall 0.00181% 29/1,603,814 alleles · very rare
Ancestry group Frequency 1 in
European (non-Finnish)grpmax 0.00239% 41,814
Remaining individualsnot grpmax-eligible 0.00161% 62,146

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
PAH
Protein
p.Phe55fs
Coding
c.165del
MANE Select
NM_000277
dbSNP
rs199475566
Type
Deletion
Location
chr12:102912794 (GRCh38)
Gene constraint
LOEUF 1.265 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 89.04 · 21 PDB
Residue 55
the act domain; a UniProt-annotated variant site (in pah deficiency; does not affect oligomerization; results in loss of substrate activation); an α-helix
Full PAH gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

phenylketonuria — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Phenylketonuria (Orphanet):

Inheritance
Autosomal recessive
Onset
Infancy
Prevalence
1-9 / 100 000 (France)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/pah-p-phe55fs (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown